Diaphragm Pacing can Enhance Recovery and Weaning from Mechanical Ventilation (MV) in Cardiac Surgery
In a press release published on PRNnewswire website, Synapse Biomedical announced today that surgeons at University Hospitals Cleveland Medical Center have improved the prognosis of several cardiac patients using TransAeris DP for the prevention and treatment of Ventilator Induced Diaphragm Dysfunction (VIDD).
Dr. Raymond Onders presented the abstract detailing these findings at the 17th Annual Perioperative and Critical Care Conference.
Following the FDA EUA recieved in April 2020, Surgeons began implanting TransLoc electrodes as a possible measure to prevent VIDD.
Patients with known risk factors for post-operative prolonged MV, such as unilateral diaphragm dysfunction and on MV pre-urgent median sternotomy, were identified for implantation. These patients all underwent extensive cardiac surgery, and range in age from 24 to 72 years old. Once in the intensive care unit, stimulation began generating a fused diaphragm contraction preventing diaphragm atrophy and VIDD.
The patients were extubated in 6.7 hours on average, a short period of time given their operation and other medical conditions. No patient was re-intubated or developed any respiratory complications. All temporary electrodes were removed completely, and all patients were discharged within 9 days post operatively.
"The ability to decrease the need for mechanical ventilation frees up more ventilator units," said Raymond Onders, MD, Chief of General and Gastrointestinal Surgery and the Remen Chair in Surgical Innovation at UH and Professor of Surgery at CWRU. "For these patients not only was this technology more efficient in weaning from the ventilator but it also decreased the complications from the ventilator. During the COVID-19 pandemic, we know it is important for all patients to reduce the amount of time they are on ventilators and this technology can potentially help."
"It is gratifying to see these positive initial results in these high-risk cardiac surgery patients," said Anthony R. Ignagni, President & CEO of Synapse Biomedical. "Anyone who has been on, or has had a loved one on, invasive mechanical ventilation knows that reducing the stress of intubation by reducing the time on the ventilator can be a substantial psychological improvement for the patient as well as reducing risks and costs."
Comments